# Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

Study · id `cardio:ct-nct02526524` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02526524](<https://clinicaltrials.gov/study/NCT02526524>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02526524

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 571 participants.

## Technical summary

Registry record NCT02526524. Randomized; quadruple masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2016-09 (actual). Results posted on 2018-04-27.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 571 participants (enrolled count; ClinicalTrials.gov record NCT02526524, source copy `cardio:ctgov-nct02526524-2018-04-27`, retrieved 2026-10-26)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02526524, source copy `cardio:ctgov-nct02526524-2018-04-27`, retrieved 2026-10-26)
- Primary completion: 2016-09 (actual) (ClinicalTrials.gov record NCT02526524, source copy `cardio:ctgov-nct02526524-2018-04-27`, retrieved 2026-10-26)
- Completion: 2016-09 (actual) (ClinicalTrials.gov record NCT02526524, source copy `cardio:ctgov-nct02526524-2018-04-27`, retrieved 2026-10-26)
- Results first posted: 2018-04-27 (ClinicalTrials.gov record NCT02526524, source copy `cardio:ctgov-nct02526524-2018-04-27`, retrieved 2026-10-26)
- Countries: United States; Puerto Rico (ClinicalTrials.gov record NCT02526524, source copy `cardio:ctgov-nct02526524-2018-04-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02526524-2018-04-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Met DR
- Intervention (Drug): Met IR
- Intervention (Drug): Placebo
- Lead sponsor: Elcelyx Therapeutics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes (`cardio:pubmed-30252913`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: adf5b80b231db322fa72a17bf5756dafac9b8ce1ee2444eb3c4c6b8fa42e73c1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
